4 Of The Best Income Stocks Around: GlaxoSmithKline plc, Standard Life Plc, SSE PLC And Centrica plc

GlaxoSmithKline plc (LON: GSK), Standard Life Plc (LON: SL), SSE PLC (LON: SSE) and Centrica PLC (LON:CNA) are four of the best dividend plays around.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Standard Life (LSE: SL) has transformed itself into an income champion over the past five years. The company’s shift to a fee-based business model has led to a tripling of cash flow generated from operations since 2010. Assets under management have risen by 50% over the same period. 

This growth has helped support the company’s dividend payout growth. Since 2011 Standard’s dividend payout has increased at a steady rate of 7% per annum. Since 2010 Standard Life has returned 147p per share to investors, including the recent special dividend and over five years the shares have produced a total return of 180%. Based on the estimated growth of the UK pension market, the next five years could see a similar performance. 

Standard Life trades at a forward P/E of 16.8 and supports a yield of 4.6%. Earnings per share are predicted to grow by 48% this year. 

Dividend concerns 

GlaxoSmithKline’s (LSE: GSK) shares have sunk to a four-year low on fears about the sustainability of the company’s dividend payout. However, to a certain extent, these concerns are unfounded.

Management has stated that the company’s dividend of 80p per share is safe for the next three years. A special dividend of 20p per share payable during the fourth quarter will take the total payout for 2015 to 100p per share, a yield of 7.9% based on Glaxo’s current share price. 

Glaxo currently trades at a forward P/E of 16.9 and supports a yield of 7.2%. Earnings per share are predicted to shrink by 21% this year. 

Slow and steady 

Last year, SSE (LSE: SSE) made a commitment to target an increase in the full-year dividend for 2015/16 of at least RPI inflation, with annual increases thereafter of at least RPI inflation also being targeted.

This is hardly the most impressive dividend policy. The RPI measure of inflation has averaged 1% this year, so investors won’t see much in the way of a dividend increase at all. 

Nevertheless, for the conservative dividend investor SSE’s dividend policy is ideal. The payout is covered 1.2 times by earnings per share and due to the nature of SSE’s business, the company has a certain degree of clarity over its revenue streams. As a result, it’s unlikely management will suddenly take an axe to the dividend. 

SSE currently trades at a forward P/E of 12.6 and supports a yield of 6.2%. Earnings per share are predicted to shrink by 10% this year.

Changing business model 

Centrica (LSE: CNA) has already cut its dividend payout once this year. However, according to City projections the new, lower payout is now covered one-and-a-half times by earnings per share, leaving plenty of room for manoeuvre. 

What’s more, management’s recent decision to scale back Centrica’s upstream business is a great move for the company. Oil & gas production is a notoriously volatile and capital intensive business. Focusing on the more predictable customer-facing side of the business should put Centrica back on the path to long-term sustainable growth.

Also, Centrica’s focus on the more predictable customer side of the business should help the company maintain and increase its dividend over time.  

Centrica currently trades at a forward P/E of 12.5 and supports a yield of 5.4%. Earnings per share are predicted to shrink by 7% this year.

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK has recommended Centrica and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Suddenly investors can’t get enough of GSK shares! What’s going on?

After years in the doldrums, GSK shares are suddenly the most bought stock on the entire FTSE 100. Harvey Jones…

Read more »

'2024' art concept overlaid on a stock screener
Investing Articles

£5,000 invested in Greggs shares in October 2024 is now worth…

Despite facing a multitude of challenges today, might Greggs' stock be worth a look after losing well over a third…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Where will Rolls-Royce shares go next? Let’s ask the experts

Rolls-Royce shares have wobbled as aviation uncertainty grows. But can the City's glowing forecasts help get the price climbing again?

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

No savings at 45? Here’s how investors could still build a £17,360 second income

It’s never too late to start investing, and with compounding working over time, Andrew Mackie shows how investors could still…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How to invest £10,000 to aim for a £6,108 annual passive income

UK REITs have been getting a lot of attention. But our author thinks they're still the place to look for…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

What sort of passive income stream could you build for a fiver a day?

Think a few pounds a day might not go far? In fact, that could be the basis of some pleasing…

Read more »

British Isles on nautical map
Investing Articles

I sense a potential opportunity if the FTSE 100 loses this quality growth stock…

Rightmove falling out of the FTSE 100 might have been unthinkable a year ago. But that's the reality investors are…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

The largest S&P 500 holding in my ISA is…

Edward Sheldon's making a large bet on this S&P 500 stock. Because he sees the long-term risk/reward proposition very attractive.

Read more »